• Relay Medical (RELA) is retaining Emerging Markets Consulting to provide investor relations advisory services
  • Emerging Markets Consulting specializes in helping small and mid-sized public companies establish brand awareness
  • It also helps increase market share to its customer base while improving visibility to the institutional and retail investment community
  • Relay Medical is down 6.17 per cent on the day, with shares trading at C$0.38 at 3:44 pm ET

Relay Medical (RELA) is retaining Emerging Markets Consulting to provide investor relations advisory services.

Emerging Markets Consulting specializes in helping small and mid-sized public companies establish brand awareness and increase market share to its customer base while improving visibility to the institutional and retail investment community.

“With the recent deployments of Toronto Airport and partnering with Canada’s largest lab company Lifelabs, Relay has a lot to share with the marketplace. We look forward to working with Emerging Markets to bring Relay to a broader audience and build on our communication as we progress through these milestones and others like the recent acquisition of Cybeats, an innovative IoT Cybersecurity company,” said Relay Medical President W. Clark Kent.

“With the termotulous year we have all faced, hope springs eternal. Working with Relay Medical is an honor and a privilege. The company’s prospects met our stringent requirements and we are happy to have Relay on our prestigious client roster,” said EMC President James Painter.

Relay Medical is a Canadian-based technology innovation company focused on the development of novel technologies in the diagnostics and AI data science and IoT security sectors.

Relay Medical is down 6.17 per cent on the day, with shares trading at C$0.38 at 3:44 pm ET.

More From The Market Online

Buzz on the Bullboards: Looking for volatility-proof stocks?

Investors saw developments in Canadian and U.S. stock markets, with attention on decisions made by central banks and moves in key sectors.
Scientific labratory

How a small-cap tech stock is broadening MRI technology 

Nanalysis Scientific (TSXV:NSCI) develops and makes compact MRI and nuclear magnetic resonance devices for clinical, lab and industrial use.

PharmAla Biotech launches educational portal for MDMA

PharmAla Biotech (CSE:MDMA) launches its Prescribers Portal for medical practitioners to learn more about MDMA.

Cancer-fighting pharma stock eyes 2027 regulatory approval

Theralase Technologies (TSXV:TLT), a cancer-fighting pharma stock, expands its team with two clinical research associates.